PharmEasy reports Rs 5,872 Cr revenue in FY25; burn remains flat

API Holdings, the parent of e-pharmacy and diagnostics brand PharmEasy, reported flat revenue in the fiscal year ending March 2025. However, the Mumbai-based company has cut losses by 38% due to sharp reduction in finance and depreciation costs during the last fiscal year.

PharmEasy’s operating revenue increased 3.7% to Rs 5,872 crore in FY25 from Rs 5,664 crore in FY24, according to the company’s financial statements reviewed by Entrackr.

PharmEasy offers pharmaceutical products, along with diagnostic services and teleconsultations, through its…